“…An additional pro-angiogenic mechanism may involve the cooperative interaction between H 2 S and eNOS-derived NO in the activation of cGMP signalling; in this system NO serves as the primary activator of this system, while H 2 S prolongs the action of cGMP by inhibiting cGMP phosphodiesterase [ 126 , 132 , 135 ]. Further mechanisms may include the upregulation of VEGF and its receptor [ 2 , 48 , 64 , 70 , 76 , [122] , [123] , [124] , [125] , [126] , [131] , [132] , [133] , [134] , [135] , [136] , [137] , [138] , [139] ] and the consequent activation of this system (possibly, in part, also via Flt induction [ 64 ]), the induction of the angiopoietin/tie system, possibly via the upregulation of Ang1 and Ang2 system [ 64 ] as well as though the upregulation of Tie [ 64 ] and, possibly, the induction of the adrenomedullin system [ 48 ] and the induction of various additional endothelial cell receptors with pro-angiogenic functions (CXCR1, VCAM1) [ 48 , 64 ]. Finally, a further mechanism may be simply related to the fact that tumors are often hypoxic, and hypoxia prolongs the biological half-life of H 2 S, which, in turn, may be more effective in exerting its various pro-angiogenic actions.…”